In conclusion, our study showed that baicalin has protective effects on thrombin-induced cell injury in HUVECs possibly through inhibition of PAR-1 expression and its downstream NF-κB activation, raising the possibility of use of baicalin as a drug for the prevention and treatment of atherosclerosis. The gene discussed is NFKB1; the disease is atherosclerosis.